Frontline BioVentures is a venture capital firm founded in 2012, primarily based in Hong Kong, China. The firm specializes in investments within the life sciences industry and has a portfolio of 17 companies, including notable investments in Guoke Hengtai Medical Technology and AnchorDx.
Focus Areas
Notable Investments
